Author holds NVO and plans to add only on good news, arguing 2026 guidance of -5% to -13% revenue decline means the stock has further to fall and this year is lost.
NVO — AVOID The author holds NVO but argues the stock has further room to fall because company guidance forecasts a 2026 revenue decline of -5% to -13%, meaning buyers today are buying a company entering a 12-month recession. The author says this year is lost and hopes for a recovery in 2027, and will only increase the position when good news appears. Stated parallel risks include political pressures and competition from Eli Lilly, and the author concludes the investment may have been right but too early.
the company itself (guidance) forecasts a decline in revenue (-5% to -13%) for 2026. By buying now, you are buying a company that is entering a recession for the next 12 months.
This Reddit post, published February 04, 2026, features u/pekebooo discussing NVO. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/pekebooo · Tickers: NVO